<DOC>
	<DOCNO>NCT00010699</DOCNO>
	<brief_summary>The primary aim present study test effect alpha-tocopherol supplementation progression carotid atherosclerosis patient coronary artery disease</brief_summary>
	<brief_title>Effect High Dose Vitamin E Carotid Atherosclerosis</brief_title>
	<detailed_description>Cardiovascular disease lead cause morbidity mortality Westernized population . Oxidation low-density lipoprotein ( LDL ) appear crucial step atherogenesis . Thus , role dietary micronutrient decrease LDL oxidation assume considerable significance . The consistent data respect micronutrient antioxidant atherosclerosis appear relate a-tocopherol ( AT ) , predominant lipid-soluble antioxidant LDL . In addition decrease LDL oxidation , data support effect AT critical cell atherogenesis ( monocyte , smooth muscle cell , endothelium ) potentially anti-atherogenic . The primary aim present study test effect AT supplementation ( 1200 IU/day RRR-AT ) placebo-controlled , randomize double blind trial 2 year progression carotid atherosclerosis patient coronary artery disease ( stable angina pectoris previous myocardial infarction ) . Subjects recruit would American Heart Association Phase II diet HMG CoA reductase inhibitor least one year LDL cholesterol &lt; 125 mg/dL 2 visit least 4 week apart 10 month lead phase . Intimal-medial thickness ( IMT ) carotids , include common carotid , bulb proximal internal carotid determine high-resolution B-mode sonography . At six month interval blood sample obtain liver enzymes , creatinine , complete blood count , lipid profile , antioxidant fatty acid level , LDL oxidation , plasma soluble CAMS ( cell adhesion molecule ) monocyte activity . Also , early morning urine sample obtain F2 -isoprostanes , direct measure lipid peroxidation . IMT determine baseline , 1 , 1.5 2 year . The mean change IMT rate progression compare AT placebo group . Following isolation , LDL subject copper catalyze oxidation 5-hour period . From obtain lag phase oxidation rate . Isolated monocyte activate lipopolysaccharide follow activity assay : superoxide anion release , interleukin-1 j3 release adhesion human endothelium . F2 isoprostanes VCAM , ICAM , E- 8 P-Selectin quantitated ELISA . AT level parameter LDL oxidation monocyte activity correlate change IMT . If study show high-dose AT supplementation beneficial retarding atherosclerosis could emerge important adjunctive therapy management cardiovascular disease .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<criteria>Must American Heart Association Phase II diet HMG CoA reductase inhibitor least one year Have LDL cholesterol &lt; 125 mg/dL 2 visit least 4 week apart 10 month lead phase .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>cvd</keyword>
</DOC>